Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial : letter to the editor
by Ruhnke, Leo (Author)
, Röllig, Christoph (Author)
, Herold, Sylvia (Author)
, Sauer, Tim (Author)
, Brandts, Christian Hubertus (Author)
, Steffen, Björn (Author)
, Schäfer-Eckart, Kerstin (Author)
, Krause, Stefan W. (Author)
, Hänel, Mathias (Author)
, Reichle, Albrecht (Author)
, Scholl, Sebastian (Author)
, Neubauer, Andreas (Author)
, Mikesch, Jan-Henrik (Author)
, Schetelig, Johannes (Author)
, Stölzel, Friedrich (Author)
, Kramer, Michael (Author)
, Haake, Annett (Author)
, Frimmel, Julia (Author)
, Krämer, Alwin (Author)
, Schlenk, Richard Friedrich (Author)
, Platzbecker, Uwe (Author)
, Serve, Hubert (Author)
, Baldus, Claudia (Author)
, Müller-Tidow, Carsten (Author)
, Aust, Daniela E. (Author)
, Bornhäuser, Martin (Author)
, Ehninger, Gerhard (Author)
, Thiede, Christian (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Editorial
Online Resource